DynPort Vaccine Company

DynPort Vaccine Company is an American biotechnology company based in Frederick, Maryland. It is “dedicated to the development and licensure of safe and efficacious biodefense vaccines.”

DynPort was founded in 1997 as a joint venture between defense contractor DynCorp and Porton International, a wholly-owned subsidiary of Ipsen.^{1) 2)} That year, the United States Department of Defense (DoD), through its Joint Vaccine Acquisition Program (JVAP), contracted DynPort to manufacture 300,000 doses of a new smallpox vaccine for the military.³⁾ The company began working on the project in 1998.

Dr. Robert Malone joined the company as Associate Director of Clinical Research in 2002, leaving the position in 2003.⁴⁾

Puppet Masters of the Pandemic. Part 1: What Did The CIA Do in Wuhan?“ Part 1 of an interview with the New American Magazine - Robert Malone Aug 3, 2023

We know that with the biodefense enterprise, broadly writ, in the United States, the CIA is intimately integrated into all levels. That's why I have all these CIA contacts is that I was brought into the biodefense community after 9/11 when I went to work for DynPort Vaccine company (because the Norwegian investors in the newco which Jill and I helped launch had pulled out after 9-11 and we had no income). ⁵⁾

On March 30, 2004, Commonwealth Biotechnologies announced it had entered a partnership with DynPort through which the companies would “co-venture wherever appropriate to compete for new biodefense vaccine development funding.”⁶⁾

DynPort developed vaccines and related biologicals for a number of diseases including:⁷⁾

• Anthrax vaccine
• Botulinum multivalent vaccine
• Plague vaccine
• Smallpox vaccine
• Tularemia vaccine
• Vaccinia immune globulin
• Venezuelan equine encephalitis (VEE) vaccine

• LinkedIn
• SourceWatch
• Website (earliest archive)